$266 Million is the total value of ARCH Venture Management, LLC's 9 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 62.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BEAM | New | BEAM THERAPEUTICS INC. | $127,530,404 | – | 5,443,039 | +100.0% | 47.94% | – |
| New | RAPPORT THERAPEUTICS, INC. | $86,730,446 | – | 3,728,738 | +100.0% | 32.60% | – | |
| ERASCA, INC. | $26,091,107 | +14.6% | 11,055,554 | 0.0% | 9.81% | -65.4% | ||
| VERV | VERVE THERAPEUTICS, INC. | $9,802,988 | -63.3% | 2,008,809 | 0.0% | 3.68% | -88.9% | |
| GOSS | GOSSAMER BIO, INC. | $7,257,575 | -23.7% | 8,055,916 | 0.0% | 2.73% | -77.0% | |
| Q32 BIO INC. | $5,752,652 | +5.3% | 320,482 | 0.0% | 2.16% | -68.2% | ||
| UNITY BIOTECHNOLOGY, INC. | $1,356,503 | -17.7% | 1,004,817 | 0.0% | 0.51% | -75.2% | ||
| New | SINGULAR GENOMICS SYSTEMS, INC. | $1,070,024 | – | 126,630 | +100.0% | 0.40% | – | |
| CERO THERAPEUTICS HOLDINGS, INC. | $431,845 | -90.3% | 1,444,296 | 0.0% | 0.16% | -97.1% | ||
| OMIC | Exit | SINGULAR GENOMICS SYSTEMS, INC. | $0 | – | -3,798,926 | -100.0% | -2.43% | – |
| DNLI | Exit | DENALI THERAPEUTICS, INC. | $0 | – | -381,249 | -100.0% | -9.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
| ERASCA, INC. | 11 | Q2 2024 | 28.4% |
| VERVE THERAPEUTICS, INC. | 11 | Q2 2024 | 33.2% |
| SINGULAR GENOMICS SYSTEMS, INC. | 10 | Q1 2024 | 4.6% |
| EQRX, INC. | 8 | Q3 2023 | 52.4% |
| DENALI THERAPEUTICS, INC. | 8 | Q1 2024 | 28.6% |
| CHIASMA INC | 8 | Q3 2020 | 25.7% |
| UNITY BIOTECHNOLOGY, INC. | 8 | Q2 2024 | 2.1% |
| KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
| KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-03 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.